Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas

NCT01857453 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

97

Enrollment

OTHER

Sponsor class

Conditions

Medulloblastoma

Interventions

DRUG: carboplatine
DRUG: Etoposide
RADIATION: radiation therapy

Sponsor

Central Hospital, Nancy, France

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]